Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Diabetologia
2003 Oct 01;4610:1375-82. doi: 10.1007/s00125-003-1198-1.
Show Gene links
Show Anatomy links
Potent and selective activation of the pancreatic beta-cell type K(ATP) channel by two novel diazoxide analogues.
Dabrowski M, Larsen T, Ashcroft FM, Bondo Hansen J, Wahl P.
???displayArticle.abstract???
AIMS/HYPOTHESIS: We investigated the pharmacological properties of two novel ATP sensitive potassium (K(ATP)) channel openers, 6-Chloro-3-isopropylamino-4 H-thieno[3,2- e]-1,2,4-thiadiazine 1,1-dioxide (NNC 55-0118) and 6-chloro-3-(1-methylcyclopropyl)amino-4 H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide (NN414), on the cloned cardiac (Kir6.2/SUR2A), smooth muscle (Kir6.2/SUR2B) and pancreatic beta cell (Kir6.2/SUR1) types of K(ATP) channel.
METHODS: We studied the effects of these compounds on whole-cell currents through cloned K(ATP) channels expressed in Xenopus oocytes or mammalian cells (HEK293). We also used inside-out macropatches excised from Xenopus oocytes.
RESULTS: In HEK 293 cells, NNC 55-0118 and NN414 activated Kir6.2/SUR1 currents with EC(50) values of 0.33 micromol/l and 0.45 micromol/l, respectively, compared with that of 31 micro mol/l for diazoxide. Neither compound activated Kir6.2/SUR2A or Kir6.2/SUR2B channels expressed in oocytes, nor did they activate Kir6.2 expressed in the absence of SUR. Current activation was dependent on the presence of intracellular MgATP, but was not supported by MgADP.
CONCLUSION/INTERPRETATION: Both NNC 55-0118 and NN414 selectively stimulate the pancreatic beta-cell type of K(ATP) channel with a higher potency than diazoxide, by interaction with the SUR1 subunit. The high selectivity and efficacy of the compounds could prove useful for treatment of disease states where inhibition of insulin secretion is beneficial.
Aguilar-Bryan,
Toward understanding the assembly and structure of KATP channels.
1998, Pubmed
Aguilar-Bryan,
Toward understanding the assembly and structure of KATP channels.
1998,
Pubmed Aguilar-Bryan,
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.
1995,
Pubmed Aizawa,
Prophylaxis of genetically determined diabetes by diazoxide: a study in a rat model of naturally occurring obese diabetes.
1995,
Pubmed Alemzadeh,
Modification of insulin resistance by diazoxide in obese Zucker rats.
1993,
Pubmed Ashcroft,
Correlating structure and function in ATP-sensitive K+ channels.
1998,
Pubmed Ashcroft,
ATP-sensitive K+ channels: a link between B-cell metabolism and insulin secretion.
1990,
Pubmed Babenko,
Pharmaco-topology of sulfonylurea receptors. Separate domains of the regulatory subunits of K(ATP) channel isoforms are required for selective interaction with K(+) channel openers.
2000,
Pubmed Björk,
Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes.
1996,
Pubmed Coghlan,
Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
2001,
Pubmed D'hahan,
Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP.
1999,
Pubmed
,
Xenbase D'hahan,
A transmembrane domain of the sulfonylurea receptor mediates activation of ATP-sensitive K(+) channels by K(+) channel openers.
1999,
Pubmed
,
Xenbase Glaser,
Genetics of neonatal hyperinsulinism.
2000,
Pubmed Gribble,
Properties of cloned ATP-sensitive K+ currents expressed in Xenopus oocytes.
1997,
Pubmed
,
Xenbase Gribble,
The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide.
1997,
Pubmed
,
Xenbase Inagaki,
Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor.
1995,
Pubmed Inagaki,
A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels.
1996,
Pubmed Isomoto,
A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel.
1996,
Pubmed Larsson,
Stimulation of the KATP channel by ADP and diazoxide requires nucleotide hydrolysis in mouse pancreatic beta-cells.
1993,
Pubmed Lawson,
Potassium channel openers as potential therapeutic weapons in ion channel disease.
2000,
Pubmed Liss,
Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons.
1999,
Pubmed Matsuoka,
C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K(+) channels.
2000,
Pubmed Miki,
Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1.
2002,
Pubmed Nielsen,
6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic beta-cells.
2002,
Pubmed Sakura,
Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscle.
1995,
Pubmed Seino,
Physiological and pathophysiological roles of ATP-sensitive K+ channels.
2003,
Pubmed Trube,
Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells.
1986,
Pubmed Tucker,
Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.
1997,
Pubmed
,
Xenbase Wahl,
Antagonist properties of a phosphono isoxazole amino acid at glutamate R1-4 (R,S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor subtypes.
1998,
Pubmed
,
Xenbase
